In December 2014, the NSW Government announced that up to $9 million over
five years would be invested in three or more clinical trials to examine how
cannabis-derived medical products can provide relief for patients including the
terminally ill.
On 27 July 2015, at Calvary Mater Hospital Newcastle the Premier announced
the trial for the terminally ill would be led by Chief Investigator Meera Agar
from the University of NSW (UNSW).
I am advised that the lead researchers are collaborating with a range of
researchers including researchers associated with the Hunter Research
Institute.
|
